Literature DB >> 21047140

The art of engineering viral nanoparticles.

Jonathan K Pokorski1, Nicole F Steinmetz.   

Abstract

Viral nanotechnology is an emerging and highly interdisciplinary field in which viral nanoparticles (VNPs) are applied in diverse areas such as electronics, energy and next-generation medical devices. VNPs have been developed as candidates for novel materials, and are often described as "programmable" because they can be modified and functionalized using a number of techniques. In this review, we discuss the concepts and methods that allow VNPs to be engineered, including (i) bioconjugation chemistries, (ii) encapsulation techniques, (iii) mineralization strategies, and (iv) film and hydrogel development. With all these techniques in hand, the potential applications of VNPs are limited only by the imagination.

Entities:  

Mesh:

Year:  2010        PMID: 21047140      PMCID: PMC3156490          DOI: 10.1021/mp100225y

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  93 in total

1.  Gold nanoparticles as spectroscopic enhancers for in vitro studies on single viruses.

Authors:  Bogdan Dragnea; Chao Chen; Eun-Soo Kwak; Barry Stein; C Cheng Kao
Journal:  J Am Chem Soc       Date:  2003-05-28       Impact factor: 15.419

2.  Cobalt ion mediated self-assembly of genetically engineered bacteriophage for biomimetic Co-Pt hybrid material.

Authors:  Soo-Kwan Lee; Dong Soo Yun; Angela M Belcher
Journal:  Biomacromolecules       Date:  2006-01       Impact factor: 6.988

Review 3.  Virus-like particles as vaccines and vessels for the delivery of small molecules.

Authors:  Robert L Garcea; Lutz Gissmann
Journal:  Curr Opin Biotechnol       Date:  2004-12       Impact factor: 9.740

4.  Monodisperse polymer-virus hybrid nanoparticles.

Authors:  Friso D Sikkema; Marta Comellas-Aragonès; Remco G Fokkink; Benedictus J M Verduin; Jeroen J L M Cornelissen; Roeland J M Nolte
Journal:  Org Biomol Chem       Date:  2006-11-17       Impact factor: 3.876

5.  Oxidative coupling of peptides to a virus capsid containing unnatural amino acids.

Authors:  Zachary M Carrico; Dante W Romanini; Ryan A Mehl; Matthew B Francis
Journal:  Chem Commun (Camb)       Date:  2008-01-29       Impact factor: 6.222

6.  A virus-based single-enzyme nanoreactor.

Authors:  Marta Comellas-Aragonès; Hans Engelkamp; Victor I Claessen; Nico A J M Sommerdijk; Alan E Rowan; Peter C M Christianen; Jan C Maan; Benedictus J M Verduin; Jeroen J L M Cornelissen; Roeland J M Nolte
Journal:  Nat Nanotechnol       Date:  2007-09-23       Impact factor: 39.213

Review 7.  Plant viruses as biotemplates for materials and their use in nanotechnology.

Authors:  Mark Young; Debbi Willits; Masaki Uchida; Trevor Douglas
Journal:  Annu Rev Phytopathol       Date:  2008       Impact factor: 13.078

8.  Viral capsids as MRI contrast agents.

Authors:  Lars Liepold; Stasia Anderson; Deborah Willits; Luke Oltrogge; Joseph A Frank; Trevor Douglas; Mark Young
Journal:  Magn Reson Med       Date:  2007-11       Impact factor: 4.668

9.  Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo.

Authors:  Pratik Singh; Duane Prasuhn; Robert M Yeh; Giuseppe Destito; Chris S Rae; Kent Osborn; M G Finn; Marianne Manchester
Journal:  J Control Release       Date:  2007-04-13       Impact factor: 9.776

Review 10.  Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.

Authors:  Emily M Plummer; Marianne Manchester
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010-09-24
View more
  62 in total

Review 1.  Virus-based nanoparticles as platform technologies for modern vaccines.

Authors:  Karin L Lee; Richard M Twyman; Steven Fiering; Nicole F Steinmetz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-01-19

2.  Photonics and plasmonics go viral: self-assembly of hierarchical metamaterials.

Authors:  Amy M Wen; Rudolf Podgornik; Giuseppe Strangi; Nicole F Steinmetz
Journal:  Rend Lincei Sci Fis Nat       Date:  2015-03-05       Impact factor: 1.627

3.  High Aspect Ratio Nanotubes Formed by Tobacco Mosaic Virus for Delivery of Photodynamic Agents Targeting Melanoma.

Authors:  Karin L Lee; Bradley L Carpenter; Amy M Wen; Reza A Ghiladi; Nicole F Steinmetz
Journal:  ACS Biomater Sci Eng       Date:  2016-03-23

4.  Biodistribution and clearance of a filamentous plant virus in healthy and tumor-bearing mice.

Authors:  Sourabh Shukla; Amy M Wen; Nadia R Ayat; Ulrich Commandeur; Ramamurthy Gopalkrishnan; Ann-Marie Broome; Kristen W Lozada; Ruth A Keri; Nicole F Steinmetz
Journal:  Nanomedicine (Lond)       Date:  2013-07-09       Impact factor: 5.307

5.  A Simple RNA-DNA Scaffold Templates the Assembly of Monofunctional Virus-Like Particles.

Authors:  Rees F Garmann; Richard Sportsman; Christian Beren; Vinothan N Manoharan; Charles M Knobler; William M Gelbart
Journal:  J Am Chem Soc       Date:  2015-06-10       Impact factor: 15.419

Review 6.  Virus-Based Nanoparticles as Versatile Nanomachines.

Authors:  Kristopher J Koudelka; Andrzej S Pitek; Marianne Manchester; Nicole F Steinmetz
Journal:  Annu Rev Virol       Date:  2015-09-25       Impact factor: 10.431

7.  Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation.

Authors:  Nicholas M Molino; Amanda K L Anderson; Edward L Nelson; Szu-Wen Wang
Journal:  ACS Nano       Date:  2013-10-09       Impact factor: 15.881

8.  Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agents.

Authors:  Michael A Bruckman; Stephen Hern; Kai Jiang; Chris A Flask; Xin Yu; Nicole F Steinmetz
Journal:  J Mater Chem B       Date:  2013-03-14       Impact factor: 6.331

Review 9.  Emerging nanotechnologies for cancer immunotherapy.

Authors:  Sourabh Shukla; Nicole F Steinmetz
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-04

10.  Endocytic uptake pathways utilized by CPMV nanoparticles.

Authors:  Emily M Plummer; Marianne Manchester
Journal:  Mol Pharm       Date:  2012-09-20       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.